1Chadban SJ, Tesch GH, Foti R, et al. Interleukin-10 diferentially modulates MHC class II expression by .mesangial cells and macrophages in vitro and in vivo, Immunology, 1998, 94(1): 72-78.
2Hawkins D.L., Mackay R.J., Mackay S. L. et al, human interleukin-10 suppresses production of inflammatory mediators by Ips-stimulated equine peritoneal macrophages, Vet immunol immunopathol, 1998, 66: 1-10.
3D'Amico G, Vulcano M, Bugarin C, et al. CD40 activation of BCP- ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergy, Blood, 2004, 104(3): 744-751.
4Moore KW, de Waal Malefyt R, Cofman RL, et al. interleukin-10 and the interleukin-10 receptor, Annu Rev Immunol, 2001, 19: 683-765.
7Ho AS, Liu Y, Khan TA, et al. A receptorfor interleukin10 is related to receptors, Proc Natl Acad Sci USA, 1993, 90(23): 11267-11271.
8Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation ofjakl and the diferential assembly of STATI and STAT3 complexes in human T cells and monocytes, J Immunol, 1995, 155(3): 1079.
9Akdis CA, Blesken T, Akdls M, et al. Role of inierieukin 10 in specific immunotherapy, J Clin Invest, 198, 102(1): 98-106.